Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
AlveoliX logo — In-vitro models inspired by nature Ι Organs-on-Chip

AlveoliX

In-vitro models inspired by nature Ι Organs-on-Chip

Founded 2019 Switzerland Bern, Switzerland 11 employees Grant Total: $30.00K Biotechnology, Life Sciences

General Information

Company Name AlveoliX
Founded Year 2019
Location Switzerland Bern, Switzerland
Employees 11
Industries Biotechnology, Life Sciences
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with AlveoliX . To contact AlveoliX , visit alveolix.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does AlveoliX compare?

A PDF of AlveoliX and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting AlveoliX soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About AlveoliX

AlveoliX AG is a biotechnology startup based in Switzerland, founded in 2019. The company's slogan "In-vitro models inspired by nature Ι Organs-on-Chip" encapsulates its vision and mission. AlveoliX aims to revolutionize drug development research by providing in-vitro models, known as organ-on-chips, that faithfully replicate the in-vivo environment. These models have the potential to enhance the predictability of drugs' responses in humans compared to traditional in-vitro and in-vivo models, consequently reducing the reliance on animal testing. The company's mission is to offer in-vitro solutions leveraging proprietary organ-on-chip technologies to improve preclinical decision-making and drive down drug development costs. Notably, AlveoliX received a grant investment from Eurostars on 19th March 2019, indicating early recognition and support for their innovative approach. This forward-looking investment aligns with the growing emphasis on ethical and effective drug development practices. AlveoliX's creation of in-vitro models that closely mirror human physiology holds promise for transforming the pharmaceutical industry.

Business keywords: In-vitro models, Organ-on-Chip, Drug development, Research, Innovation, Technology, 3D Cell Culture, Respiratory diseases, Drug Discovery, Preclinical Services, Safety, Efficacy, Toxicity, Inhalation

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant Undisclosed 1
Eurostars
19 Mar 2019
Grant Fr.20.00K -
25 Jun 2014
Grant Fr.10.00K -
04 Feb 2014

AlveoliX Alternatives & Competitors

View All Alternatives
AlveoliX vs
Emulate, Inc.
Emulate, Inc. United States

Our Organ-on-a-Chip technology provides a high-fidelity window into the inner workings of human biol...

Series F
71 employees
Biotechnology, Health Care
AlveoliX vs
Qureator
Qureator United States

Create to Cure

Series A
22 employees
Biotechnology, Life Sciences
AlveoliX vs
React4life
React4life Italy

Mirroring Human Complexity

Debt Financing
13 employees
Biotechnology, Health Care
View all alternatives

FAQ About AlveoliX

In-vitro models inspired by nature Ι Organs-on-Chip
AlveoliX was founded in 2019.
AlveoliX is headquartered in Bern, Switzerland.
AlveoliX operates in Biotechnology and Life Sciences. Its work centres on In-vitro models, Organ-on-Chip, Drug development and Research.
AlveoliX has approximately 11 employees.
AlveoliX has completed 3 funding rounds, raising a total of $30.00K. The latest funding stage is Grant.
Top alternatives and competitors to AlveoliX include Emulate, Inc., Qureator , React4life, InvivoSciences® Inc., Lena Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AlveoliX and Emulate, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AlveoliX , https://bouncewatch.com/company/alveolix-ag, updated 29 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout